Division of Medical Protein Chemistry, Department of Translational Medicine, Lund University, Malmö, Sweden.
Division of Medical Protein Chemistry, Department of Translational Medicine, Lund University, Malmö, Sweden.
Mol Immunol. 2018 Oct;102:73-83. doi: 10.1016/j.molimm.2018.05.023. Epub 2018 Jun 7.
The complement system resembles a double-edged sword since its activation can either benefit or harm the host. Thus, regulation of this system is of utmost importance and performed by several circulating and membrane-bound complement inhibitors. The pool of well-established regulators has recently been enriched with proteins that either share structural homology to known complement inhibitors such as Sushi domain-containing (SUSD) protein family and Human CUB and Sushi multiple domains (CSMD) families or extracellular matrix (ECM) macromolecules that interact with and modulate complement activity. In this review, we summarize the current knowledge about newly discovered complement inhibitors and discuss their implications in complement regulation, as well as in processes beyond complement regulation such cancer development. Understanding the behavior of these proteins will introduce new mechanisms of complement regulation and may provide new avenues in the development of novel therapies.
补体系统就像一把双刃剑,因为其激活既可以有益于宿主,也可以伤害宿主。因此,对该系统的调节至关重要,是由几种循环和膜结合的补体抑制剂来完成的。最近,大量的新的已知补体抑制剂结构同源物或细胞外基质(ECM)大分子被发现,这些物质可以与补体相互作用并调节其活性,从而丰富了已经确立的调节剂池。在这篇综述中,我们总结了关于新发现的补体抑制剂的最新知识,并讨论了它们在补体调节以及补体调节以外的过程(如癌症发展)中的意义。了解这些蛋白质的行为将引入新的补体调节机制,并可能为新疗法的开发提供新途径。